The present provides a synergistic insecticidal composition comprising Chlorantraniliprole. Methoxy fenozide and at least one insecticidal compound selected from Deltamethrin or Lambda-Cyhalothrin. process of preparation of the composition and uses thereof.

Nanoparticles of N-halamine-derivatized crosslinked polyamide. Process of preparing the polymeric nanoparticles per se and incorporated in or on a substrate. Uses of the polymeric nanoparticles and of substrates incorporating same, particularly for reducing a formation of organic based contaminants, e.g., load of a microorganism or of a biofilm.

Nanoparticles of N-halamine-derivatized crosslinked polyamide. Process of preparing the polymeric nanoparticles per se and incorporated in or on a substrate. Uses of the polymeric nanoparticles and of substrates incorporating same, particularly for reducing a formation of organic based contaminants, e.g., load of a microorganism or of a biofilm.

An antimicrobial composition with a synergistic combination of ingredients is described. Cosmetic compositions containing the antimicrobial composition with improved preservation properties are also described. The cosmetic compositions are effective in treating the skin to cleanse, moisturize and to reduce the effects of aging and photo damage and treat other skin conditions after being topically applied.

An antimicrobial composition with a synergistic combination of ingredients is described. Cosmetic compositions containing the antimicrobial composition with improved preservation properties are also described. The cosmetic compositions are effective in treating the skin to cleanse, moisturize and to reduce the effects of aging and photo damage and treat other skin conditions after being topically applied.

Methods are disclosed herein for at least one of (i) substantially reducing Plasmodium and/or oocyst development, (ii) substantially reducing mating success, (iii) substantially abolishing egg development after blood feeding, (iv) substantially reducing the mean survival rate; (v) substantially reducing at least one of the transmission of mosquito borne pathogens; and (vi) substantially reducing the propensity for mosquito biting comprising contacting adult, female mosquitoes with a composition comprising an effective amount of one or more non-steroidal ecdysone agonists. The one or more non-steroidal ecdysone agonists can be comprised indoor or outdoor surface.

Substituted aryl- and heteroarylcarbonyl hydrazides

The invention relates to substituted aryl- and heteroarylcarbonyl hydrazides of the general formula (I) or salts thereof

##STR00001##

where the radicals of the formula (I) are each as defined in the description for enhancing stress tolerance in plants to abiotic stress, and for enhancing plant growth and/or for increasing plant yield.

Substituted aryl- and heteroarylcarbonyl hydrazides

The invention relates to substituted aryl- and heteroarylcarbonyl hydrazides of the general formula (I) or salts thereof

##STR00001##

where the radicals of the formula (I) are each as defined in the description for enhancing stress tolerance in plants to abiotic stress, and for enhancing plant growth and/or for increasing plant yield.

The present disclosure provides boron-containing diacylhydrazines having Formula I:

##STR00001##

and the pharmaceutically acceptable salts and solvates thereof, wherein A, R.sup.4, and R.sup.5 are defined as set forth in the specification. The present disclosure also provides the use of boron-containing diacylhydrazines is ecdysone receptor-based inducible gene expression systems. Thus, the present disclosure is useful for applications such as gene therapy, treatment of disease, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable.

The present disclosure provides boron-containing diacylhydrazines having Formula I:

##STR00001##

and the pharmaceutically acceptable salts and solvates thereof, wherein A, R.sup.4, and R.sup.5 are defined as set forth in the specification. The present disclosure also provides the use of boron-containing diacylhydrazines is ecdysone receptor-based inducible gene expression systems. Thus, the present disclosure is useful for applications such as gene therapy, treatment of disease, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable.